Larry Biegelsen
Stock Analyst at Wells Fargo
(2.89)
# 1,637
Out of 4,670 analysts
280
Total ratings
57.89%
Success rate
27.16%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Overweight | $106 → $98 | $86.21 | +13.68% | 17 | Nov 20, 2024 | |
| GKOS Glaukos | Maintains: Overweight | $135 → $145 | $144.00 | +0.69% | 11 | Nov 5, 2024 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $187 → $198 | $188.73 | +4.91% | 10 | Nov 5, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $95 → $96 | $82.44 | +16.45% | 2 | Oct 31, 2024 | |
| BLCO Bausch + Lomb | Maintains: Overweight | $23 → $26 | $19.57 | +32.86% | 3 | Oct 31, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $110 → $117 | $110.22 | +6.15% | 9 | Oct 31, 2024 | |
| SYK Stryker | Maintains: Overweight | $381 → $405 | $384.85 | +5.24% | 13 | Oct 30, 2024 | |
| DXCM DexCom | Maintains: Overweight | $80 → $90 | $72.83 | +23.58% | 8 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Overweight | $87 → $98 | $90.00 | +8.89% | 11 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $466 → $549 | $547.87 | +0.21% | 17 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $166 | $155.17 | +6.98% | 12 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $85 → $103 | $105.33 | -2.21% | 6 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $70.48 | +13.51% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $115 | $100.80 | +14.09% | 15 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $85.99 | +22.11% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $40 | $33.21 | +20.45% | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $54 | $44.83 | +20.46% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $55 | $30.81 | +78.51% | 7 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $10 | $6.79 | +47.28% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $84 → $65 | $49.66 | +30.89% | 5 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $289 → $150 | $244.84 | -38.74% | 13 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $17.73 | +125.61% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $14 | $4.52 | +209.73% | 11 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.1 → $1.6 | $1.02 | +56.86% | 3 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $23.58 | +107.80% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $241 → $236 | $191.71 | +23.10% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $117.76 | +15.49% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $84.72 | -17.37% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $224.00 | +20.54% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $90.52 | - | 2 | Nov 2, 2017 |
Medtronic
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $86.21
Upside: +13.68%
Glaukos
Nov 5, 2024
Maintains: Overweight
Price Target: $135 → $145
Current: $144.00
Upside: +0.69%
Inspire Medical Systems
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $187 → $198
Current: $188.73
Upside: +4.91%
GE HealthCare Technologies
Oct 31, 2024
Maintains: Overweight
Price Target: $95 → $96
Current: $82.44
Upside: +16.45%
Bausch + Lomb
Oct 31, 2024
Maintains: Overweight
Price Target: $23 → $26
Current: $19.57
Upside: +32.86%
Zimmer Biomet Holdings
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $110 → $117
Current: $110.22
Upside: +6.15%
Stryker
Oct 30, 2024
Maintains: Overweight
Price Target: $381 → $405
Current: $384.85
Upside: +5.24%
DexCom
Oct 25, 2024
Maintains: Overweight
Price Target: $80 → $90
Current: $72.83
Upside: +23.58%
Boston Scientific
Oct 24, 2024
Maintains: Overweight
Price Target: $87 → $98
Current: $90.00
Upside: +8.89%
Intuitive Surgical
Oct 18, 2024
Maintains: Overweight
Price Target: $466 → $549
Current: $547.87
Upside: +0.21%
Oct 16, 2024
Maintains: Equal-Weight
Price Target: $163 → $166
Current: $155.17
Upside: +6.98%
Sep 16, 2024
Maintains: Equal-Weight
Price Target: $85 → $103
Current: $105.33
Upside: -2.21%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $70.48
Upside: +13.51%
Aug 29, 2024
Maintains: Overweight
Price Target: $110 → $115
Current: $100.80
Upside: +14.09%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $85.99
Upside: +22.11%
Aug 7, 2024
Maintains: Equal-Weight
Price Target: $44 → $40
Current: $33.21
Upside: +20.45%
Aug 6, 2024
Maintains: Overweight
Price Target: $68 → $54
Current: $44.83
Upside: +20.46%
Aug 2, 2024
Maintains: Overweight
Price Target: $50 → $55
Current: $30.81
Upside: +78.51%
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $14 → $10
Current: $6.79
Upside: +47.28%
Jul 31, 2024
Maintains: Overweight
Price Target: $84 → $65
Current: $49.66
Upside: +30.89%
Jul 31, 2024
Downgrades: Equal-Weight
Price Target: $289 → $150
Current: $244.84
Upside: -38.74%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $17.73
Upside: +125.61%
Apr 8, 2024
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $4.52
Upside: +209.73%
Mar 22, 2024
Maintains: Equal-Weight
Price Target: $2.1 → $1.6
Current: $1.02
Upside: +56.86%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $23.58
Upside: +107.80%
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $241 → $236
Current: $191.71
Upside: +23.10%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $117.76
Upside: +15.49%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $84.72
Upside: -17.37%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $224.00
Upside: +20.54%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $90.52
Upside: -